The Increasing Prevalence of TMJ Disorders is expected to Boost the Growth of the Global TMJ Disorders Market at a CAGR of 7.10% during the Forecast Period

Pune, India, March 2022, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global TMJ Disorders Market.

Market Highlights

Global TMJ Disorders Market is expected to register a CAGR of 7.10% during the forecast period and is expected to hit USD 758 Million by 2030.

TMJ disorders are commonly known as temporomandibular joint and muscle disorders. This is a medical condition that causes dysfunction and pain in the jaw joint and the muscles that control jaw movement. It is more common in women than men. Factors that drive the market growth are rising introduction and rapid adoption of advanced treatments, easy availability of medicines, increasing prevalence of TMJ disorders, and rise in healthcare spending worldwide.

TMJ disorders are the second-most commonly occurring musculoskeletal conditions resulting in pain and disability. The incidence of TMJ peaks from the age of 20-40 years, and it is found to be more prevalent in women than men. Moreover, women who use supplemental estrogen or oral contraceptives are more likely to seek treatment for these conditions. Therefore, the rising prevalence of these disorders in these populations is propelling the market growth. Several research studies focused on studying the prevalence of TMJ disorders are anticipated to drive market growth. For instance, a prevalence study was conducted in 2016 among the university students of North Saudi Arabia which reported a high prevalence rate among these students. Clicking and pain were the most prevalent finding of TMD, with females having more of these symptoms. A similar study was published in the Indian Association of Public Health Dentistry in 2016 to estimate the prevalence of TMD and its association with parafunctional habits among senior-secondary school children of Lucknow, India. The habits, especially digit-sucking, nail-biting, mouth breathing, and clenching, had statistically significantly associated with TMD. Such research studies are fueling the market growth of TMJ disorders.

Segment Analysis

Global TMJ Disorders Market, based on Type, is segmented into Myofascial Pain, Internal Derangement (ID), and Osteoarthritis. The global TMJ disorders market, based on treatment, is segmented into medication, therapies, surgical, and others. The medication segment is further sub-segmented into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others. Based on end user, the global TMJ disorders market is categorized into hospitals and clinics, ambulatory surgery centers, academic institutes, and others.

Regional Analysis

Global TMJ Disorder Market has been segmented on the basis of regions into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas market has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The market in Europe has been segmented into Western Europe and Eastern Europe. The Western Europe TMJ disorder market is further classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been divided into the Middle East and Africa. The Americas held the largest market share of 49.20% of the TMJ disorder market in 2019. This share can be attributed to the introduction and rapid adoption of advanced treatments in the region.

Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the high incidence of TMJ disorder, increased government initiative, and the presence of a large number of pharmaceutical companies. Various initiatives taken by the government to support the healthcare system are also fueling the growth of the regional market.

Explore In-depth Details: TMJ Disorders Market Research Report

Key Players

MRFR recognizes the following companies as the Key Players in the global TMJ Disorders market— Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited.

Key Findings of the Study

• Global TMJ Disorders Market was valued at USD 474.61 Million and is expected to register a CAGR of 4.18% during the assessment period.


• The Americas accounted for the largest global market share, which is majorly attributed to the introduction and rapid adoption of advanced treatments in the region.


• Based on type, the myofascial pain segment accounted for the largest market share of 39.73% in 2019.


• Based on treatment, the medication segment dominated the market with a value of 46.31% in 2019.


• Based on end-user, the hospitals & clinics segment dominated the market with a value of 51.9% in 2019.